Merging of ruxolitinib and vorinostat leads to highly potent inhibitors of JAK2 and histone deacetylase 6 (HDAC6)

Merging of ruxolitinib and vorinostat leads to highly potent inhibitors of JAK2 and histone deacetylase 6 (HDAC6)

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Bioorganic & Medicinal Chemistry Letters - Volume 28, Issue 15, 15 August 2018, Pages 2636-2640

Lianbin Yao, Pondy Murugappan Ramanujulu, Anders Poulsen, Sten Ohlson, Brian W. Dymock,